Falanga, Anna <br/><br/>
Hypercoagulation screening as an innovative tool for risk assessment, early diagnosis and prognosis in cancer: the HYPERCAN study.  [electronic resource] 

 -  Thrombosis research  Apr 2016 
 - S55-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-2472 
<br/><br/><label>Standard No.: </label>10.1016/S0049-3848(16)30099-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Blood Coagulation<br/>Blood Coagulation Tests--methods<br/>Early Detection of Cancer--methods<br/>Female<br/>Humans<br/>Italy--epidemiology<br/>Male<br/>Mass Screening<br/>Middle Aged<br/>Neoplasms--blood<br/>Prognosis<br/>Prospective Studies<br/>Risk Assessment<br/>Thrombosis--blood